Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.

Končar IB, Davidović LB, Savić N, Sinđelić RB, Ilić N, Dragas M, Markovic M, Kostic D.

J Vasc Surg. 2011 Apr;53(4):1032-7. doi: 10.1016/j.jvs.2010.07.075. Epub 2011 Jan 7.

2.

Invited commentary.

Hoch JR.

J Vasc Surg. 2011 Apr;53(4):1037-8. doi: 10.1016/j.jvs.2010.10.061. No abstract available.

3.

Investigation of outcomes following recombinant activated FVII use for refractory bleeding during abdominal aortic aneurysm repair.

Kandane-Rathnayake RK, Willis CD, Beiles CB, Bourke BM, Cameron PA, McCall P, Phillips LE.

Eur J Vasc Endovasc Surg. 2013 Jun;45(6):617-25. doi: 10.1016/j.ejvs.2013.01.028. Epub 2013 Feb 21.

4.

[Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures].

Koncar IB, Savić N, Davidović LB, Simić D, Marković D, Sindjelić R.

Srp Arh Celok Lek. 2008 Jul-Aug;136(7-8):367-72. Serbian.

5.

Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.

Yan W, Xuan C, Ma G, Zhang L, Dong N, Wang Z, Xu R.

J Cardiothorac Surg. 2014 Sep 2;9:156. doi: 10.1186/s13019-014-0156-y.

6.
7.

[The use of recombinant activated factor VIIa for major bleedings in open heart surgery].

Ingimarsson JP, Onundarson PT, Valsson F, Vidarsson B, Gudbjartsson T.

Laeknabladid. 2008 Sep;94(9):607-12. Icelandic.

PMID:
18784387
8.

Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.

von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, Wernecke KD, Spies C.

Crit Care Med. 2005 Oct;33(10):2241-6.

PMID:
16215377
9.

Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.

Razon Y, Erez E, Vidne B, Birk E, Katz J, Tamari H, Dagan O.

Paediatr Anaesth. 2005 Mar;15(3):235-40.

PMID:
15725322
10.

Recombinant activated factor VII and aortic surgery.

Thompson JF.

Eur J Vasc Endovasc Surg. 2013 Jun;45(6):626. doi: 10.1016/j.ejvs.2013.03.001. Epub 2013 Mar 24. No abstract available.

11.

Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.

Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.

Transfusion. 2013 Apr;53(4):798-804. doi: 10.1111/j.1537-2995.2012.03801.x. Epub 2012 Jul 31.

PMID:
22845023
12.

Intraoperative blood product resuscitation and mortality in ruptured abdominal aortic aneurysm.

Kauvar DS, Sarfati MR, Kraiss LW.

J Vasc Surg. 2012 Mar;55(3):688-92. doi: 10.1016/j.jvs.2011.10.028. Epub 2012 Jan 24.

13.

Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.

Filsoufi F, Castillo JG, Rahmanian PB, Scurlock C, Fischer G, Adams DH.

Ann Thorac Surg. 2006 Nov;82(5):1779-83.

PMID:
17062247
14.

Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.

Chapman AJ, Blount AL, Davis AT, Hooker RL.

Eur J Cardiothorac Surg. 2011 Dec;40(6):1314-8; discussion 1318-9. doi: 10.1016/j.ejcts.2011.03.048. Epub 2011 May 20.

PMID:
21601468
15.

The association of perioperative transfusion with 30-day morbidity and mortality in patients undergoing major vascular surgery.

Obi AT, Park YJ, Bove P, Cuff R, Kazmers A, Gurm HS, Grossman PM, Henke PK.

J Vasc Surg. 2015 Apr;61(4):1000-9.e1. doi: 10.1016/j.jvs.2014.10.106. Epub 2015 Jan 14.

16.

Intraoperative use of recombinant activated factor VII (rFVIIa).

De Gasperi A.

Minerva Anestesiol. 2006 Jun;72(6):489-94. Review.

17.

Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.

Tatoulis J, Theodore S, Meswani M, Wynne R, Hon-Yap C, Powar N.

Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):459-62. doi: 10.1510/icvts.2009.204735. Epub 2009 Jun 18.

PMID:
19542087
18.

Intraoperative use of packed red blood cell transfusion and mortality in patients undergoing abdominal or thoracoabdominal aortic aneurysm surgery.

Kertai MD, Tiszai-Szûcs T, Varga KS, Hermann C, Acsády G, Gal J.

J Cardiovasc Surg (Torino). 2009 Aug;50(4):501-8. Epub 2009 Apr 1.

PMID:
19339959
19.

Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery?

Warren OJ, Alcock EM, Choong AM, Leff DR, Van Herzeele I, Darzi AW, Athanasiou T, Cheshire NJ.

Eur J Vasc Endovasc Surg. 2008 Feb;35(2):145-52. Epub 2007 Oct 25. Review.

20.

Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.

Rao VK, Lobato RL, Bartlett B, Klanjac M, Mora-Mangano CT, Soran PD, Oakes DA, Hill CC, van der Starre PJ.

J Cardiothorac Vasc Anesth. 2014 Oct;28(5):1221-6. doi: 10.1053/j.jvca.2014.04.015.

PMID:
25281040

Supplemental Content

Support Center